Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
Jan 6, 2025 · Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million. The two companies have been collaborating on the Dundalk site since 2019, when WuXi agreed to build the vaccine manufacturing facility.
China's WuXi Biologics to sell Irish vaccine facility to Merck as US ...
Jan 6, 2025 · China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million, ahead of potential U.S. legislation that would restrict...
Merck buys Ireland vaccines plant from troubled WuXi for €500M
Jan 6, 2025 · With potential passage of the BIOSECURE Act looming, WuXi Biologics has sold a new vaccines plant in Ireland to Merck & Co. for €500 million ($521 million).
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Jan 7, 2025 · WuXi Biologics has announced the sale of its Dundalk, Ireland-based vaccine manufacturing facility to Merck for US$500 million. This news comes shortly after its parent company, WuXi AppTec, revealed plans to reduce its operational footprint.
Merck to buy WuXi Biologics' Irish vaccine facility for $500 million
Jan 7, 2025 · WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland to MSD International, a subsidiary of Merck & Co. for approximately...
“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in …
Jan 16, 2025 · News. Today's news ; US ; Politics ; World ... Ireland to Merck & Co. for approximately $500m, the company announced earlier in January. ... the Financial Times reported that WuXi Biologics was in ...
China’s WuXi Biologics sells Irish vaccine facility to Merck for …
Jan 6, 2025 · Chinese CDMO WuXi Biologics is selling its vaccine manufacturing facility in Dundalk, Ireland, for approximately $500 million to Merck, known as MSD outside of the U.S. and Canada. MSD and WuXi Biologics have been collaborating on the site in Dundalk since 2019, when construction began.
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 …
WuXi 2269 -3.08% Biologics agreed to sell an overseas vaccine facility to Merck MRK -1.72% & Co. for half a billion dollars, a move that could strengthen the company’s cash flow and margins as...
WuXi Biologics sells Irish facility to Merck for US$500M
Jan 7, 2025 · USA—Chinese biotech firm WuXi Biologics has announced plans to sell its vaccine manufacturing facility in Dundalk, Ireland, to U.S. pharmaceutical giant Merck & Co. for approximately US$500 million.
WuXi Biologics to Sell Vaccine Facility in Ireland to Merck for …
Jan 6, 2025 · WuXi Biologics plans to sell its vaccine facility in Dundalk, Ireland to Merck & Co. for approximately $500 million. This comes as U.S. legislation aims to restrict WuXi Biologics business in the U.S.